Chong‐De Lu

565 total citations · 1 hit paper
16 papers, 376 citations indexed

About

Chong‐De Lu is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Chong‐De Lu has authored 16 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hepatology, 9 papers in Surgery and 5 papers in Epidemiology. Recurrent topics in Chong‐De Lu's work include Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers) and Liver Disease and Transplantation (3 papers). Chong‐De Lu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers) and Liver Disease and Transplantation (3 papers). Chong‐De Lu collaborates with scholars based in China, Hong Kong and United States. Chong‐De Lu's co-authors include Xiaohui Fu, Shuqun Cheng, Wei‐Xing Guo, Xiaoping Yao, Wan Yee Lau, Jie Xue, Hongwei Zhang, Hui Dong, Dong Xie and Shupeng Liu and has published in prestigious journals such as Nature Medicine, Journal of Hepatology and The Oncologist.

In The Last Decade

Chong‐De Lu

13 papers receiving 372 citations

Hit Papers

Adjuvant sintilimab in resected high-risk hepatocellular ... 2024 2026 2025 2024 20 40 60

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chong‐De Lu China 9 155 141 131 118 101 16 376
Yannan Bai China 10 197 1.3× 88 0.6× 84 0.6× 113 1.0× 131 1.3× 34 418
Nicolai Aagaard Schultz Denmark 9 79 0.5× 149 1.1× 121 0.9× 81 0.7× 147 1.5× 21 322
Wentao Wang China 11 167 1.1× 78 0.6× 72 0.5× 77 0.7× 83 0.8× 21 328
Bing Quan China 9 158 1.0× 74 0.5× 79 0.6× 58 0.5× 98 1.0× 24 300
Sayo Kobayashi Japan 12 118 0.8× 70 0.5× 116 0.9× 96 0.8× 52 0.5× 30 375
Erlei Zhang China 16 293 1.9× 153 1.1× 166 1.3× 118 1.0× 104 1.0× 61 562
Hesham M. Hassabo United States 8 191 1.2× 113 0.8× 174 1.3× 70 0.6× 159 1.6× 17 401
De-Chuan Chan Taiwan 13 121 0.8× 71 0.5× 115 0.9× 242 2.1× 120 1.2× 33 477
P. Merle United States 3 195 1.3× 79 0.6× 95 0.7× 60 0.5× 60 0.6× 5 333
Wusheng Lu China 12 220 1.4× 88 0.6× 43 0.3× 100 0.8× 96 1.0× 30 338

Countries citing papers authored by Chong‐De Lu

Since Specialization
Citations

This map shows the geographic impact of Chong‐De Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chong‐De Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chong‐De Lu more than expected).

Fields of papers citing papers by Chong‐De Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chong‐De Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chong‐De Lu. The network helps show where Chong‐De Lu may publish in the future.

Co-authorship network of co-authors of Chong‐De Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Chong‐De Lu. A scholar is included among the top collaborators of Chong‐De Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chong‐De Lu. Chong‐De Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Wang, Lei, Chong‐De Lu, Jiayi Wu, et al.. (2024). Salvage Surgery for Initially Unresectable HCC With PVTT Converted by Locoregional Treatment Plus Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody. The Oncologist. 29(8). e1041–e1050. 2 indexed citations
4.
Wang, Kang, Yan‐Jun Xiang, Hongming Yu, et al.. (2024). Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial. Nature Medicine. 30(3). 708–715. 64 indexed citations breakdown →
5.
Zhang, Yuqing, Chong‐De Lu, Liu Xu, et al.. (2023). Transarterial chemoembolization plus immune checkpoint inhibitor as postoperative adjuvant therapy for hepatocellular carcinoma with portal vein tumor thrombus: A multicenter cohort study. European Journal of Surgical Oncology. 49(7). 1226–1233. 5 indexed citations
8.
Zhou, Bin, Tianwei Chen, Yabo Jiang, et al.. (2020). Scinderin suppresses cell proliferation and predicts the poor prognosis of hepatocellular carcinoma. Oncology Letters. 19(3). 2011–2020. 3 indexed citations
9.
Zhang, Fan, Chong‐De Lu, Xiuping Zhang, et al.. (2019). The impact of portal vein tumor thrombus on long-term survival after liver resection for primary hepatic malignancy. HPB. 22(7). 1025–1033. 9 indexed citations
10.
Li, Nan, Jie Xue, Wei‐Xing Guo, et al.. (2015). Cidan inhibits liver cancer cell growth by reducing COX-2 and VEGF expression and cell cycle arrest. Experimental and Therapeutic Medicine. 9(5). 1709–1718. 16 indexed citations
11.
Yang, Tian, Han Zhang, Jun‐Hua Lu, et al.. (2014). Risk Factors of Surgical Site Infection after Hepatic Resection. Infection Control and Hospital Epidemiology. 35(3). 317–320. 15 indexed citations
12.
Lu, Chong‐De, et al.. (2013). Hepatitis B virus-related combined hepatocellular-cholangiocarcinoma. European Journal of Gastroenterology & Hepatology. 26(2). 192–199. 58 indexed citations
13.
Zhang, Han, Shuyang Dai, Xing Huang, et al.. (2013). Tumor Size Does Not Independently Affect Long‐Term Survival after Curative Resection of Solitary Hepatocellular Carcinoma Without Macroscopic Vascular Invasion. World Journal of Surgery. 38(4). 947–957. 43 indexed citations
14.
Liu, Shupeng, Wei‐Xing Guo, Jie Shi, et al.. (2011). MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma. Journal of Hepatology. 56(2). 389–396. 132 indexed citations
15.
Lai, Eric C. H., Xiaoping Yao, Hongwei Zhang, et al.. (2010). Vitamin Analogues in Chemoprevention of Hepatocellular Carcinoma After Resection or Ablation—A Systematic Review and Meta-analysis. Asian Journal of Surgery. 33(3). 120–126. 20 indexed citations
16.
Fu, Xiaohui, Chong‐De Lu, Xiaoping Yao, et al.. (2009). The Hepatoprotective Effect of Hypothermic Perfusion of Normal Saline in Period of Inflow Occlusion of Liver in Rats. Journal of Surgical Research. 166(1). 104–108. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026